Pfizer (PFE), AstraZeneca (AZN), Johnson & Johnson (JNJ), and other drug company shares fell in Monday's premarket activity after US President Donald Trump vowed to sign an executive order to reduce prescription drug prices for Americans.
"We are going to do the right thing," Trump wrote Sunday on his Truth Social account. "I will be signing one of the most consequential Executive Orders in our Country's history. Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%."
Novo Nordisk (NVO) shares were down around 3.8% pre-bell, while Pfizer shares were down nearly 3.5%, AstraZeneca shares dropped 2.7%, and Johnson & Johnson declined 2.6%.
Bristol-Myers Squibb (BMY) and Merck (MRK) both fell 2.4%, Eli Lilly (LLY) was down 2.2%, and GSK (GSK) around 2%.
Trump said he will institute a policy whereby the US will pay the same price for prescription drugs as the lowest price anywhere in the world.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。